💊 Same Drug, Different Label

Ozempic vs Wegovy

Both are semaglutide. Both are made by Novo Nordisk. So why do two separate brands exist, and which should you ask your doctor about?

0
Ozempic Max Dose (mg)
0
Wegovy Max Dose (mg)
0
STEP 1 Weight Loss %

💊 Ozempic

  • Active Ingredient
    Semaglutide
  • FDA Approval
    Type 2 Diabetes (2017)
  • Available Doses
    0.25, 0.5, 1, 2 mg
  • Max Dose
    2 mg/week
  • Weight Loss (off-label)
    ~10–14% at 1–2 mg
  • Insurance
    Widely covered for T2D
  • Delivery
    Weekly SC injection (pen)

💊 Wegovy

  • Active Ingredient
    Semaglutide
  • FDA Approval
    Chronic Weight Management (2021)
  • Available Doses
    0.25, 0.5, 1, 1.7, 2.4 mg
  • Max Dose
    2.4 mg/week
  • Weight Loss
    14.9% at 2.4 mg (STEP 1)
  • Insurance
    Variable — many plans exclude
  • Delivery
    Weekly SC injection (pen)

🔑 The Key Difference Is FDA Labeling, Not Chemistry

Ozempic and Wegovy contain the exact same molecule — semaglutide. Novo Nordisk created two brands because the FDA requires separate approvals for different indications. Ozempic was approved for type 2 diabetes in 2017; Wegovy was approved for obesity in 2021 at a higher max dose (2.4 mg vs 2 mg).

Dose Comparison

Wegovy max dose2.4 mg
2.4 mg
Ozempic max dose2.0 mg
2.0 mg
Rybelsus max dose (oral)14 mg (oral)
14 mg oral

The 0.4 mg difference between Ozempic's max (2 mg) and Wegovy's max (2.4 mg) translates to roughly 2–4% additional weight loss at the higher dose.

Insurance & Cost Reality

This is where the brands really differ — and why most people end up with Ozempic instead of Wegovy:

Why Two Brands Exist

This isn't unusual in pharma. It's a business strategy:

Also in this family: Rybelsus — oral semaglutide tablets (max 14 mg), approved for T2D. Same molecule, third delivery method.

⚖️ Who Should Choose What?

Ozempic makes sense if:
  • You have type 2 diabetes (or can get it prescribed off-label)
  • Your insurance covers Ozempic but not Wegovy
  • You're comfortable with the 2 mg maximum dose
  • Cost is your primary concern
Wegovy makes sense if:
  • Your primary goal is weight loss (on-label use)
  • Your insurance covers anti-obesity medications
  • You want the full 2.4 mg dose for maximum effect
  • You're participating in a clinical or employer wellness program that covers it
Bottom Line:

They're the same drug. The "choice" is usually made by your insurance company, not your doctor. If both are equally accessible, Wegovy's slightly higher dose is marginally better for weight loss. But Ozempic at 2 mg is nearly identical in practice. Don't overpay for a label.

Frequently Asked Questions

Are Ozempic and Wegovy the same drug?

Yes. Both contain semaglutide made by Novo Nordisk. Ozempic is approved for type 2 diabetes (max 2 mg), Wegovy for weight management (max 2.4 mg).

Can I use Ozempic instead of Wegovy for weight loss?

Doctors frequently prescribe Ozempic off-label for weight loss, especially when Wegovy isn't covered. The max dose is slightly lower (2 mg vs 2.4 mg), but results are similar.

Which is cheaper, Ozempic or Wegovy?

List prices are similar, but insurance coverage differs dramatically. Most plans cover Ozempic for diabetes; fewer cover Wegovy for weight loss. Compounded semaglutide is the cheapest option where available.

Is Wegovy more effective than Ozempic?

Marginally. Wegovy's higher max dose (2.4 mg vs 2 mg) may produce 2–4% more weight loss. The STEP 1 trial at 2.4 mg showed 14.9% mean weight loss.

What about Rybelsus?

Rybelsus is oral semaglutide (tablets) approved for type 2 diabetes. Max dose is 14 mg daily. Less effective for weight loss than injectable forms but an option for people who dislike needles.

🛒 Recommended Products

Tools to support your semaglutide journey

Affiliate links help support MeetPeptide at no extra cost to you.

Related Comparisons & Tools

More semaglutide resources

⚕️ Disclaimer: This comparison is for educational purposes only. Both Ozempic and Wegovy are prescription medications. Consult your healthcare provider. Data from published clinical trials (STEP program) and FDA labeling.